subject: Aarkstore Enterprise --- Can-fite Biopharma Ltd. (cfbi) - Financial And Strategic Analysis Review [print this page] Aarkstore announce a new report " Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic Analysis Review" through its vast collection of market research report.
Can-Fite BioPharma Ltd.(Can-Fite) is a biopharmaceutical company engaged in development of molecule-based drugs for the treatment of cancer and autoimmune inflammatory diseases. The company's product pipeline includes orally administered small molecules drugs. Its CF101 is targeted at rheumatoid arthritis, dry eye syndrome and psoriasis. CF102 is targeted for treating liver diseases including hepatocellular carcinoma, Hepatitis C and liver regeneration; CF502 is a A3AR agonists targeted at autoimmune inflammatory diseases, and CF602.
Can-Fite BioPharma Ltd. Key Recent Developments
Jan 20, 2010: Can-Fite Signs MOU With Morningside
Sep 30, 2009: Can-Fite Initiates Preparatory Work For Psoriasis Phase III Trial
Sep 07, 2009: Can-Fite Reports Positive Results Of Phase II Trial For CF101
Jul 14, 2009: Can-Fite To Initiate Phase I/II Hepatitis C Trial
This comprehensive SWOT profile of Can-Fite BioPharma Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Can-Fite BioPharma Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
